Compugroup Medical (ETR:COP) received a €63.00 ($77.78) price target from stock analysts at Deutsche Bank in a research report issued to clients and investors on Monday. The brokerage presently has a “buy” rating on the stock. Deutsche Bank’s target price would indicate a potential upside of 34.33% from the stock’s current price.

A number of other research firms also recently issued reports on COP. Baader Bank set a €52.00 ($64.20) price objective on shares of Compugroup Medical and gave the company a “neutral” rating in a report on Wednesday, December 13th. Berenberg Bank set a €49.00 ($60.49) price target on shares of Compugroup Medical and gave the stock a “neutral” rating in a report on Wednesday, February 7th. Commerzbank set a €60.00 ($74.07) price target on shares of Compugroup Medical and gave the stock a “buy” rating in a report on Monday, February 5th. set a €61.00 ($75.31) price target on shares of Compugroup Medical and gave the stock a “buy” rating in a report on Wednesday, October 18th. Finally, Warburg Research set a €58.00 ($71.60) price target on shares of Compugroup Medical and gave the stock a “buy” rating in a report on Friday, January 26th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of €57.57 ($71.08).

Shares of Compugroup Medical (COP) opened at €46.90 ($57.90) on Monday. The stock has a market cap of $2,500.00 and a PE ratio of 57.20. Compugroup Medical has a twelve month low of €37.51 ($46.31) and a twelve month high of €60.30 ($74.44).

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://theolympiareport.com/2018/02/12/compugroup-medical-cop-pt-set-at-63-00-by-deutsche-bank.html.

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.